Peter S. Hoffmeister, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Sinus | 1 | 2012 | 84 | 0.380 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2012 | 122 | 0.370 |
Why?
|
Cardiac Pacing, Artificial | 4 | 2024 | 866 | 0.340 |
Why?
|
Defibrillators, Implantable | 5 | 2024 | 1488 | 0.320 |
Why?
|
Cardiac Resynchronization Therapy | 3 | 2024 | 553 | 0.310 |
Why?
|
Electric Countershock | 3 | 2021 | 533 | 0.280 |
Why?
|
Pacemaker, Artificial | 3 | 2024 | 808 | 0.270 |
Why?
|
Arrhythmias, Cardiac | 4 | 2021 | 2248 | 0.260 |
Why?
|
Mediastinum | 1 | 2007 | 267 | 0.260 |
Why?
|
Tomography, Spiral Computed | 1 | 2007 | 273 | 0.250 |
Why?
|
Atrial Fibrillation | 7 | 2024 | 5126 | 0.230 |
Why?
|
Mitral Valve Insufficiency | 2 | 2024 | 1404 | 0.230 |
Why?
|
Heart Atria | 2 | 2007 | 1347 | 0.230 |
Why?
|
Ultrasonography, Interventional | 1 | 2012 | 1494 | 0.220 |
Why?
|
Electrodes, Implanted | 1 | 2006 | 839 | 0.190 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2024 | 355 | 0.170 |
Why?
|
Heart Failure | 5 | 2024 | 11653 | 0.170 |
Why?
|
Loperamide | 1 | 2017 | 9 | 0.150 |
Why?
|
Electrocardiography | 4 | 2017 | 6380 | 0.140 |
Why?
|
Antidiarrheals | 1 | 2017 | 46 | 0.140 |
Why?
|
Ventricular Function, Left | 3 | 2024 | 3876 | 0.130 |
Why?
|
Device Removal | 1 | 2021 | 630 | 0.130 |
Why?
|
Stroke Volume | 3 | 2024 | 5487 | 0.120 |
Why?
|
Catheter Ablation | 2 | 2007 | 2752 | 0.120 |
Why?
|
United States Department of Veterans Affairs | 1 | 2018 | 923 | 0.110 |
Why?
|
Amiodarone | 2 | 2012 | 216 | 0.100 |
Why?
|
Death, Sudden, Cardiac | 1 | 2021 | 1554 | 0.100 |
Why?
|
Esophagus | 2 | 2007 | 1030 | 0.090 |
Why?
|
Tachycardia, Ventricular | 2 | 2012 | 1304 | 0.090 |
Why?
|
Equipment Failure | 1 | 2012 | 578 | 0.090 |
Why?
|
Syncope | 1 | 2012 | 427 | 0.080 |
Why?
|
Heart Rate | 3 | 2021 | 4190 | 0.080 |
Why?
|
Prosthesis Implantation | 1 | 2012 | 592 | 0.070 |
Why?
|
Cause of Death | 3 | 2024 | 3686 | 0.070 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2012 | 850 | 0.070 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2008 | 1066 | 0.070 |
Why?
|
Causality | 1 | 2012 | 1243 | 0.070 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2007 | 263 | 0.060 |
Why?
|
Aortography | 1 | 2007 | 420 | 0.060 |
Why?
|
Patient Admission | 1 | 2012 | 1367 | 0.060 |
Why?
|
Anaphylaxis | 1 | 2012 | 757 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2272 | 0.060 |
Why?
|
Hospitalization | 1 | 2024 | 10698 | 0.060 |
Why?
|
Statistics, Nonparametric | 2 | 2008 | 2852 | 0.060 |
Why?
|
Angina Pectoris | 1 | 2007 | 959 | 0.050 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2018 | 4569 | 0.050 |
Why?
|
Motor Activity | 1 | 2013 | 2710 | 0.050 |
Why?
|
Ventricular Fibrillation | 1 | 2005 | 537 | 0.050 |
Why?
|
Aspirin | 1 | 2014 | 3134 | 0.050 |
Why?
|
Fluoroscopy | 1 | 2006 | 947 | 0.050 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2012 | 2117 | 0.050 |
Why?
|
Risk Assessment | 3 | 2024 | 23953 | 0.050 |
Why?
|
Risk Factors | 7 | 2024 | 74055 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2021 | 64591 | 0.040 |
Why?
|
Contrast Media | 1 | 2012 | 5310 | 0.040 |
Why?
|
Pulmonary Artery | 1 | 2007 | 1938 | 0.040 |
Why?
|
Male | 14 | 2024 | 360035 | 0.040 |
Why?
|
Myocardial Ischemia | 1 | 2008 | 2110 | 0.040 |
Why?
|
Aged | 10 | 2024 | 168840 | 0.040 |
Why?
|
Humans | 19 | 2024 | 760437 | 0.040 |
Why?
|
Time Factors | 3 | 2024 | 39947 | 0.040 |
Why?
|
Veterans Health | 1 | 2018 | 215 | 0.030 |
Why?
|
Middle Aged | 10 | 2024 | 220382 | 0.030 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2012 | 776 | 0.030 |
Why?
|
Coronary Angiography | 1 | 2006 | 4468 | 0.030 |
Why?
|
Prognosis | 2 | 2024 | 29551 | 0.030 |
Why?
|
Action Potentials | 1 | 2021 | 1830 | 0.030 |
Why?
|
Prevalence | 2 | 2024 | 15698 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12429 | 0.020 |
Why?
|
Israel | 1 | 2012 | 722 | 0.020 |
Why?
|
Female | 9 | 2024 | 391875 | 0.020 |
Why?
|
Survival Rate | 1 | 2023 | 12698 | 0.020 |
Why?
|
Incidence | 2 | 2021 | 21322 | 0.020 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2008 | 174 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2024 | 58859 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2017 | 2318 | 0.020 |
Why?
|
Sotalol | 1 | 2005 | 47 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12054 | 0.010 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2007 | 578 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2007 | 629 | 0.010 |
Why?
|
Injections | 1 | 2007 | 829 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10494 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2006 | 20551 | 0.010 |
Why?
|
Cell Count | 1 | 2007 | 1834 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7948 | 0.010 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2005 | 506 | 0.010 |
Why?
|
Opioid-Related Disorders | 1 | 2017 | 2152 | 0.010 |
Why?
|
Exercise Tolerance | 1 | 2007 | 835 | 0.010 |
Why?
|
Stroke | 1 | 2024 | 9745 | 0.010 |
Why?
|
Adult | 3 | 2017 | 220781 | 0.010 |
Why?
|
Cardiovascular Agents | 1 | 2007 | 840 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9639 | 0.010 |
Why?
|
Exercise Test | 1 | 2008 | 2127 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2005 | 1240 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2646 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2014 | 14565 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14661 | 0.010 |
Why?
|
Prospective Studies | 2 | 2014 | 54339 | 0.010 |
Why?
|
Quality of Life | 2 | 2008 | 13338 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2006 | 5236 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2007 | 8522 | 0.010 |
Why?
|
Myocardium | 1 | 2007 | 4700 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2018 | 80430 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20078 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2006 | 4063 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2007 | 12320 | 0.010 |
Why?
|
Cohort Studies | 1 | 2014 | 41366 | 0.010 |
Why?
|
United States | 1 | 2018 | 72202 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2006 | 8967 | 0.010 |
Why?
|
Adolescent | 1 | 2012 | 88196 | 0.000 |
Why?
|